Next, we set out to investigate vaccine-induced CD8+ T cell immunity after mRNA vaccination in patients with MM without prior SARS-CoV-2 infection (based on reporting and anti-nucleocapsid IgG testing). This evidence concerns the gene CD8A and Miyoshi myopathy.